Therefore, understanding the effects of anti-β2GP1-β2GP1 complexes on platelets is important not only to determine the mechanism(s) of interaction, but to also potentially assist in the development of novel or improved treatments for patients with autoimmune diseases. This evidence concerns the gene APOH and autoimmune disease.